title: Measles antibody prevalence after mass immunization campaign in Niterói, state of Rio de Janeiro, Brazil.
abstract: Three months after a mass vaccination campaign (coverage: 100%) against measles a random seroepidemiological survey was carried out in students aged 1 to 19 years old in the Municipality of Niterói, State of Rio de Janeiro. Blood samples were tested for measles antibodies by enzyme immunosorbent assay (EIA) and negative cases were tested again using hemagglutination inhibition (HI) and plaque reduction neutralization (PRN). Of the 798 samples tested by EIA, 718 (90.2%) were positive for measles antibodies. PRN test was more sensitive than EIA and HI in detecting measles specific antibodies. The total antibody prevalence increased from 90.2% to 93.2% when HI was employed in EIA negative specimens and to 98.9% when PRN was used. After the mass vaccination campaign a marked decrease in measles incidence was observed in the municipality studied, showing the effectiveness of the strategy used for measles control in developing countries.
authors.affiliation: Disciplina de Doenças Infecciosas, Faculdade de Medicina, Universidade Federal Fluminense, Niterói, RJ, Brazil.
authors.forename: S A
authors.initials: SA
authors.lastname: Oliveira
authors.forename: M M
authors.initials: MM
authors.lastname: Siqueira
authors.forename: G F
authors.initials: GF
authors.lastname: Mann
authors.forename: A J
authors.initials: AJ
authors.lastname: Costa
authors.forename: M T
authors.initials: MT
authors.lastname: Almeida
authors.forename: M S
authors.initials: MS
authors.lastname: Stavola
authors.forename: H
authors.initials: H
authors.lastname: Tomasini
authors.forename: J P
authors.initials: JP
authors.lastname: Nascimento
mesh_terms: D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D006801:Humans; D017589:Immunization Programs; D015994:Incidence; D007223:Infant; D008457:Measles / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control; D008458:Measles Vaccine; D008459:Measles virus / Q000276:immunology*; D015995:Prevalence; D016036:Seroepidemiologic Studies
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine